{"metadata" : {"frameRate":"30","generator":"Presenter","generatorVersion":"11.0.0","launchFile":"index.htm","pptxLoop":"0","title":"Chapitre 1 :  Aspects Pharmacodynamiques","totalSlides":"45",
"durationInMS":"2042440"} ,
"contentStructure" : [{ "id" :"1256","class" :"slide","title" :"Chapitre 1 : \nAspects Pharmacodynamiques","roles" : {"navigation" :{ "navid":"dy256" },"slide" :{ "durationInMS":"43600","hidePlaybar":"false" } },"children" :[ "1000001","256001" ],"thumbnail" : "data\/resources\/ha\/Diapositive1.PNG"},
{ "id" :"256001","roles" : {"audio" :{ "URI":"a24x1.mp3","duration":"43600","title":"Pr_1" } }},
{ "id" :"1257","class" :"slide","title" :"La pharmacodynamie ","roles" : {"navigation" :{ "navid":"dy257" },"slide" :{ "durationInMS":"57530","hidePlaybar":"false" } },"children" :[ "1000001","257001" ],"thumbnail" : "data\/resources\/ha\/Diapositive3.PNG"},
{ "id" :"257001","roles" : {"audio" :{ "URI":"a24x3.mp3","duration":"57530","title":"Pr_3" } }},
{ "id" :"1258","class" :"slide","roles" : {"navigation" :{ "navid":"dy258" },"slide" :{ "durationInMS":"5000","hidePlaybar":"false" } },"children" :[ "1000001","258001" ],"thumbnail" : "data\/resources\/ha\/Diapositive45.PNG"},
{ "id" :"258001","roles" : {"audio" :{ "URI":"a24x40.mp3","duration":"5000","title":"Pr_40" } }},
{ "id" :"1259","class" :"slide","roles" : {"navigation" :{ "navid":"dy259" },"slide" :{ "durationInMS":"110190","hidePlaybar":"false" } },"children" :[ "1000001","259001" ],"thumbnail" : "data\/resources\/ha\/Diapositive2.PNG"},
{ "id" :"259001","roles" : {"audio" :{ "URI":"a24x2.mp3","duration":"110190","title":"Pr_2" } }},
{ "id" :"1260","class" :"slide","title" :" Antagoniste compétitif","roles" : {"navigation" :{ "navid":"dy260" },"slide" :{ "durationInMS":"116370","hidePlaybar":"false" } },"children" :[ "1000001","260001" ],"thumbnail" : "data\/resources\/ha\/Diapositive30.PNG"},
{ "id" :"260001","roles" : {"audio" :{ "URI":"a24x27.mp3","duration":"116370","title":"Pr_27" } }},
{ "id" :"1261","class" :"slide","title" :"Réponses quantitatives","roles" : {"navigation" :{ "navid":"dy261" },"slide" :{ "durationInMS":"140100","hidePlaybar":"false" } },"children" :[ "1000001","261001" ],"thumbnail" : "data\/resources\/ha\/Diapositive13.PNG"},
{ "id" :"261001","roles" : {"audio" :{ "URI":"a24x8.mp3","duration":"140100","title":"Pr_8" } }},
{ "id" :"1262","class" :"slide","title" :"Relation concentration\/effet","roles" : {"navigation" :{ "navid":"dy262" },"slide" :{ "durationInMS":"48970","hidePlaybar":"false" } },"children" :[ "1000001","262001" ],"thumbnail" : "data\/resources\/ha\/Diapositive14.PNG"},
{ "id" :"262001","roles" : {"audio" :{ "URI":"a24x9.mp3","duration":"48970","title":"Pr_9" } }},
{ "id" :"1266","class" :"slide","title" :"Principaux paramètres \npharmacodynamiques","roles" : {"navigation" :{ "navid":"dy266" },"slide" :{ "durationInMS":"32820","hidePlaybar":"false" } },"children" :[ "1000001","266001" ],"thumbnail" : "data\/resources\/ha\/Diapositive25.PNG"},
{ "id" :"266001","roles" : {"audio" :{ "URI":"a24x22.mp3","duration":"32820","title":"Pr_22" } }},
{ "id" :"1274","class" :"slide","title" :"Comparaison de puissance et \nd’efficacité de plusieurs ligands agonistes","roles" : {"navigation" :{ "navid":"dy274" },"slide" :{ "durationInMS":"62780","hidePlaybar":"false" } },"children" :[ "1000001","274001" ],"thumbnail" : "data\/resources\/ha\/Diapositive26.PNG"},
{ "id" :"274001","roles" : {"audio" :{ "URI":"a24x23.mp3","duration":"62780","title":"Pr_23" } }},
{ "id" :"1275","class" :"slide","title" :"Le type de réponse étudiée","roles" : {"navigation" :{ "navid":"dy275" },"slide" :{ "durationInMS":"41880","hidePlaybar":"false" } },"children" :[ "1000001","275001" ],"thumbnail" : "data\/resources\/ha\/Diapositive12.PNG"},
{ "id" :"275001","roles" : {"audio" :{ "URI":"a24x7.mp3","duration":"41880","title":"Pr_7" } }},
{ "id" :"1278","class" :"slide","title" :"Notion de marge thérapeutique","roles" : {"navigation" :{ "navid":"dy278" },"slide" :{ "durationInMS":"88600","hidePlaybar":"false" } },"children" :[ "1000001","278001" ],"thumbnail" : "data\/resources\/ha\/Diapositive37.PNG"},
{ "id" :"278001","roles" : {"audio" :{ "URI":"a24x32.mp3","duration":"88600","title":"Pr_32" } }},
{ "id" :"1280","class" :"slide","title" :"Notion de marge thérapeutique","roles" : {"navigation" :{ "navid":"dy280" },"slide" :{ "durationInMS":"44080","hidePlaybar":"false" } },"children" :[ "1000001","280001" ],"thumbnail" : "data\/resources\/ha\/Diapositive38.PNG"},
{ "id" :"280001","roles" : {"audio" :{ "URI":"a24x33.mp3","duration":"44080","title":"Pr_33" } }},
{ "id" :"1281","class" :"slide","title" :"Notion d’antagoniste","roles" : {"navigation" :{ "navid":"dy281" },"slide" :{ "durationInMS":"22470","hidePlaybar":"false" } },"children" :[ "1000001","281001" ],"thumbnail" : "data\/resources\/ha\/Diapositive28.PNG"},
{ "id" :"281001","roles" : {"audio" :{ "URI":"a24x25.mp3","duration":"22470","title":"Pr_25" } }},
{ "id" :"1283","class" :"slide","title" :"Notion d’antagoniste compétitif","roles" : {"navigation" :{ "navid":"dy283" },"slide" :{ "durationInMS":"19520","hidePlaybar":"false" } },"children" :[ "1000001","283001" ],"thumbnail" : "data\/resources\/ha\/Diapositive29.PNG"},
{ "id" :"283001","roles" : {"audio" :{ "URI":"a24x26.mp3","duration":"19520","title":"Pr_26" } }},
{ "id" :"1284","class" :"slide","title" :"Toxicologie des principes actifs","roles" : {"navigation" :{ "navid":"dy284" },"slide" :{ "durationInMS":"78390","hidePlaybar":"false" } },"children" :[ "1000001","284001" ],"thumbnail" : "data\/resources\/ha\/Diapositive42.PNG"},
{ "id" :"284001","roles" : {"audio" :{ "URI":"a24x37.mp3","duration":"78390","title":"Pr_37" } }},
{ "id" :"1287","class" :"slide","title" :"Notion de concentration efficace 50","roles" : {"navigation" :{ "navid":"dy287" },"slide" :{ "durationInMS":"48020","hidePlaybar":"false" } },"children" :[ "1000001","287001" ],"thumbnail" : "data\/resources\/ha\/Diapositive23.PNG"},
{ "id" :"287001","roles" : {"audio" :{ "URI":"a24x20.mp3","duration":"48020","title":"Pr_20" } }},
{ "id" :"1288","class" :"slide","title" :"Notion de concentration efficace 50","roles" : {"navigation" :{ "navid":"dy288" },"slide" :{ "durationInMS":"14370","hidePlaybar":"false" } },"children" :[ "1000001","288001" ],"thumbnail" : "data\/resources\/ha\/Diapositive24.PNG"},
{ "id" :"288001","roles" : {"audio" :{ "URI":"a24x21.mp3","duration":"14370","title":"Pr_21" } }},
{ "id" :"1290","class" :"slide","title" :"Relation concentration-effet","roles" : {"navigation" :{ "navid":"dy290" },"slide" :{ "durationInMS":"39510","hidePlaybar":"false" } },"children" :[ "1000001","290001" ],"thumbnail" : "data\/resources\/ha\/Diapositive16.PNG"},
{ "id" :"290001","roles" : {"audio" :{ "URI":"a24x11.mp3","duration":"39510","title":"Pr_11" } }},
{ "id" :"1291","class" :"slide","title" :"Relation concentration-effet","roles" : {"navigation" :{ "navid":"dy291" },"slide" :{ "durationInMS":"33070","hidePlaybar":"false" } },"children" :[ "1000001","291001" ],"thumbnail" : "data\/resources\/ha\/Diapositive15.PNG"},
{ "id" :"291001","roles" : {"audio" :{ "URI":"a24x10.mp3","duration":"33070","title":"Pr_10" } }},
{ "id" :"1295","class" :"slide","title" :"Relation dose-réponse en toxicologie","roles" : {"navigation" :{ "navid":"dy295" },"slide" :{ "durationInMS":"29610","hidePlaybar":"false" } },"children" :[ "1000001","295001" ],"thumbnail" : "data\/resources\/ha\/Diapositive43.PNG"},
{ "id" :"295001","roles" : {"audio" :{ "URI":"a24x38.mp3","duration":"29610","title":"Pr_38" } }},
{ "id" :"1296","class" :"slide","title" :"Relation dose-réponse en toxicologie","roles" : {"navigation" :{ "navid":"dy296" },"slide" :{ "durationInMS":"52560","hidePlaybar":"false" } },"children" :[ "1000001","296001" ],"thumbnail" : "data\/resources\/ha\/Diapositive44.PNG"},
{ "id" :"296001","roles" : {"audio" :{ "URI":"a24x39.mp3","duration":"52560","title":"Pr_39" } }},
{ "id" :"1297","class" :"slide","title" :"Quantification de la puissance\nd’un antagoniste compétitif","roles" : {"navigation" :{ "navid":"dy297" },"slide" :{ "durationInMS":"43610","hidePlaybar":"false" } },"children" :[ "1000001","297001" ],"thumbnail" : "data\/resources\/ha\/Diapositive31.PNG"},
{ "id" :"297001","roles" : {"audio" :{ "URI":"a24x28.mp3","duration":"43610","title":"Pr_28" } }},
{ "id" :"1301","class" :"slide","title" :"Quantification de la puissance\nd’un antagoniste compétitif","roles" : {"navigation" :{ "navid":"dy301" },"slide" :{ "durationInMS":"70910","hidePlaybar":"false" } },"children" :[ "1000001","301001" ],"thumbnail" : "data\/resources\/ha\/Diapositive32.PNG"},
{ "id" :"301001","roles" : {"audio" :{ "URI":"a24x29.mp3","duration":"70910","title":"Pr_29" } }},
{ "id" :"1313","class" :"slide","title" :"Aspects\nPharmacologiques\n\nPrincipaux paramètres pharmacodynamiques","roles" : {"navigation" :{ "navid":"dy313" },"slide" :{ "durationInMS":"9670","hidePlaybar":"false" } },"children" :[ "1000001","313001" ],"thumbnail" : "data\/resources\/ha\/Diapositive18.PNG"},
{ "id" :"313001","roles" : {"audio" :{ "URI":"a24x13.mp3","duration":"9670","title":"Pr_13" } }},
{ "id" :"1316","class" :"slide","title" :"Aspects\nPharmacologiques\n\nNotion de marge\nthérapeutique","roles" : {"navigation" :{ "navid":"dy316" },"slide" :{ "durationInMS":"5000","hidePlaybar":"false" } },"children" :[ "1000001","316001" ],"thumbnail" : "data\/resources\/ha\/Diapositive36.PNG"},
{ "id" :"316001","roles" : {"audio" :{ "URI":"a24x31.mp3","duration":"3000","title":"Pr_31" } }},
{ "id" :"1317","class" :"slide","title" :"Aspects\nPharmacologiques\n\nNotion de toxicité\ndes médicaments","roles" : {"navigation" :{ "navid":"dy317" },"slide" :{ "durationInMS":"5000","hidePlaybar":"false" } },"children" :[ "1000001","317001" ],"thumbnail" : "data\/resources\/ha\/Diapositive41.PNG"},
{ "id" :"317001","roles" : {"audio" :{ "URI":"a24x36.mp3","duration":"5000","title":"Pr_36" } }},
{ "id" :"1319","class" :"slide","title" :"Médicaments à marge thérapeutique étroite","roles" : {"navigation" :{ "navid":"dy319" },"slide" :{ "durationInMS":"70540","hidePlaybar":"false" } },"children" :[ "1000001","319001" ],"thumbnail" : "data\/resources\/ha\/Diapositive39.PNG"},
{ "id" :"319001","roles" : {"audio" :{ "URI":"a24x34.mp3","duration":"70540","title":"Pr_34" } }},
{ "id" :"1322","class" :"slide","title" :"Activité intrinsèque d’un agoniste","roles" : {"navigation" :{ "navid":"dy322" },"slide" :{ "durationInMS":"53040","hidePlaybar":"false" } },"children" :[ "1000001","322001" ],"thumbnail" : "data\/resources\/ha\/Diapositive20.PNG"},
{ "id" :"322001","roles" : {"audio" :{ "URI":"a24x17.mp3","duration":"53040","title":"Pr_17" } }},
{ "id" :"1323","class" :"slide","title" :"Les différents types de ligands","roles" : {"navigation" :{ "navid":"dy323" },"slide" :{ "durationInMS":"104680","hidePlaybar":"false" } },"children" :[ "1000001","323001" ],"thumbnail" : "data\/resources\/ha\/Diapositive21.PNG"},
{ "id" :"323001","roles" : {"audio" :{ "URI":"a24x18.mp3","duration":"104680","title":"Pr_18" } }},
{ "id" :"1324","class" :"slide","title" :"Notion d’agoniste\nentier - agoniste partiel","roles" : {"navigation" :{ "navid":"dy324" },"slide" :{ "durationInMS":"52900","hidePlaybar":"false" } },"children" :[ "1000001","324001" ],"thumbnail" : "data\/resources\/ha\/Diapositive22.PNG"},
{ "id" :"324001","roles" : {"audio" :{ "URI":"a24x19.mp3","duration":"52900","title":"Pr_19" } }},
{ "id" :"1325","class" :"slide","title" :"Les niveaux d’étude de l’affinité et de l’activité des principes actifs","roles" : {"navigation" :{ "navid":"dy325" },"slide" :{ "durationInMS":"60760","hidePlaybar":"false" } },"children" :[ "1000001","325001" ],"thumbnail" : "data\/resources\/ha\/Diapositive5.PNG"},
{ "id" :"325001","roles" : {"audio" :{ "URI":"a24x6.mp3","duration":"60760","title":"Pr_6" } }},
{ "id" :"1329","class" :"slide","title" :"Objectifs\/Plan du cours","roles" : {"navigation" :{ "navid":"dy329" },"slide" :{ "durationInMS":"5920","hidePlaybar":"false" } },"children" :[ "1000001","329001" ],"thumbnail" : "data\/resources\/ha\/Diapositive35.PNG"},
{ "id" :"329001","roles" : {"audio" :{ "URI":"a24x30.mp3","duration":"5920","title":"Pr_30" } }},
{ "id" :"1330","class" :"slide","title" :"Objectifs\/Plan du cours","roles" : {"navigation" :{ "navid":"dy330" },"slide" :{ "durationInMS":"7850","hidePlaybar":"false" } },"children" :[ "1000001","330001" ],"thumbnail" : "data\/resources\/ha\/Diapositive40.PNG"},
{ "id" :"330001","roles" : {"audio" :{ "URI":"a24x35.mp3","duration":"7850","title":"Pr_35" } }},
{ "id" :"1331","class" :"slide","title" :"Comparaison de puissance et \nd’efficacité de plusieurs ligands agonistes","roles" : {"navigation" :{ "navid":"dy331" },"slide" :{ "durationInMS":"26090","hidePlaybar":"false" } },"children" :[ "1000001","331001" ],"thumbnail" : "data\/resources\/ha\/Diapositive27.PNG"},
{ "id" :"331001","roles" : {"audio" :{ "URI":"a24x24.mp3","duration":"26090","title":"Pr_24" } }},
{ "id" :"1332","class" :"slide","title" :"Objectifs\/Plan du cours","roles" : {"navigation" :{ "navid":"dy332" },"slide" :{ "durationInMS":"45450","hidePlaybar":"false" } },"children" :[ "1000001","332001" ],"thumbnail" : "data\/resources\/ha\/Diapositive4.PNG"},
{ "id" :"332001","roles" : {"audio" :{ "URI":"a24x4.mp3","duration":"45450","title":"Pr_4" } }},
{ "id" :"1333","class" :"slide","title" :"Aspects\nPharmacologiques\n\nNotion d’affinité d’un ligand pour son récepteur","roles" : {"navigation" :{ "navid":"dy333" },"slide" :{ "durationInMS":"29740","hidePlaybar":"false" } },"children" :[ "1000001","333001" ],"thumbnail" : "data\/resources\/ha\/Diapositive6.PNG"},
{ "id" :"333001","roles" : {"audio" :{ "URI":"a24x41.mp3","duration":"29740","title":"Pr_41" } }},
{ "id" :"1334","class" :"slide","title" :"Affinité et modèle de la loi d’action de masse","roles" : {"navigation" :{ "navid":"dy334" },"slide" :{ "durationInMS":"98000","hidePlaybar":"false" } },"children" :[ "1000001","334001" ],"thumbnail" : "data\/resources\/ha\/Diapositive7.PNG"},
{ "id" :"334001","roles" : {"audio" :{ "URI":"a24x14.mp3","duration":"98000","title":"Pr_14" } }},
{ "id" :"1335","class" :"slide","title" :"Etudes de liaisons","roles" : {"navigation" :{ "navid":"dy335" },"slide" :{ "durationInMS":"36590","hidePlaybar":"false" } },"children" :[ "1000001","335001" ],"thumbnail" : "data\/resources\/ha\/Diapositive8.PNG"},
{ "id" :"335001","roles" : {"audio" :{ "URI":"a24x45.mp3","duration":"36590","title":"Pr_45" } }},
{ "id" :"1336","class" :"slide","title" :"Notion de constante d’affinité","roles" : {"navigation" :{ "navid":"dy336" },"slide" :{ "durationInMS":"73180","hidePlaybar":"false" } },"children" :[ "1000001","336001" ],"thumbnail" : "data\/resources\/ha\/Diapositive9.PNG"},
{ "id" :"336001","roles" : {"audio" :{ "URI":"a24x15.mp3","duration":"73180","title":"Pr_15" } }},
{ "id" :"1337","class" :"slide","title" :"Objectifs\/Plan du cours","roles" : {"navigation" :{ "navid":"dy337" },"slide" :{ "durationInMS":"13420","hidePlaybar":"false" } },"children" :[ "1000001","337001" ],"thumbnail" : "data\/resources\/ha\/Diapositive10.PNG"},
{ "id" :"337001","roles" : {"audio" :{ "URI":"a24x42.mp3","duration":"13420","title":"Pr_42" } }},
{ "id" :"1338","class" :"slide","title" :"Aspects\nPharmacologiques\n\nRelations concentrations (ou doses) -effets","roles" : {"navigation" :{ "navid":"dy338" },"slide" :{ "durationInMS":"13440","hidePlaybar":"false" } },"children" :[ "1000001","338001" ],"thumbnail" : "data\/resources\/ha\/Diapositive11.PNG"},
{ "id" :"338001","roles" : {"audio" :{ "URI":"a24x43.mp3","duration":"13440","title":"Pr_43" } }},
{ "id" :"1339","class" :"slide","title" :"Objectifs\/Plan du cours","roles" : {"navigation" :{ "navid":"dy339" },"slide" :{ "durationInMS":"6190","hidePlaybar":"false" } },"children" :[ "1000001","339001" ],"thumbnail" : "data\/resources\/ha\/Diapositive17.PNG"},
{ "id" :"339001","roles" : {"audio" :{ "URI":"a24x44.mp3","duration":"6190","title":"Pr_44" } }},
{ "id" :"1340","class" :"slide","title" :"Notion d’activité intrinsèque","roles" : {"navigation" :{ "navid":"dy340" },"slide" :{ "durationInMS":"18520","hidePlaybar":"false" } },"children" :[ "1000001","340001" ],"thumbnail" : "data\/resources\/ha\/Diapositive19.PNG"},
{ "id" :"340001","roles" : {"audio" :{ "URI":"a24x46.mp3","duration":"18520","title":"Pr_46" } }},
{ "id" :"1341","class" :"slide","title" :"Antagonisme non compétitif","roles" : {"navigation" :{ "navid":"dy341" },"slide" :{ "durationInMS":"24240","hidePlaybar":"false" } },"children" :[ "1000001","341001" ],"thumbnail" : "data\/resources\/ha\/Diapositive33.PNG"},
{ "id" :"341001","roles" : {"audio" :{ "URI":"a24x48.mp3","duration":"24240","title":"Pr_48" } }},
{ "id" :"1342","class" :"slide","title" :" Antagoniste non compétitif","roles" : {"navigation" :{ "navid":"dy342" },"slide" :{ "durationInMS":"38260","hidePlaybar":"false" } },"children" :[ "1000001","342001" ],"thumbnail" : "data\/resources\/ha\/Diapositive34.PNG"},
{ "id" :"342001","roles" : {"audio" :{ "URI":"a24x49.mp3","duration":"38260","title":"Pr_49" } }},
{ "id" :"11001","roles" : {"slide" :{ "durationInMS":"0" } }},
{ "id" :"11002","roles" : {"slide" :{ "durationInMS":"0" } }},
{ "id" :"11003","roles" : {"slide" :{ "durationInMS":"0" } }},
{ "id" :"11004","roles" : {"slide" :{ "durationInMS":"0" } }},
{ "id" :"11005","roles" : {"slide" :{ "durationInMS":"0" } }},
{ "id" :"11006","roles" : {"slide" :{ "durationInMS":"0" } }},
{ "id" :"21001","roles" : {"slide" :{ "durationInMS":"0" } }},
{ "id" :"21002","roles" : {"slide" :{ "durationInMS":"0" } }},
{ "id" :"1000001","class" :"speaker","roles" : {"speaker" :{ "company":"Professeur CHU Grenoble (Université Joseph Fourier)","name":"Françoise Stanke-Labesque","thumbnail":"data\/spk58806.jpg" } }}],
"contentSettings" : {"global":{"pptxAutoPlay":"true", "showPresentationTitle":"true", "showSpeakerBio":"false", "showSpeakerEmail":"false", "showSpeakerImage":"true", "showSpeakerLogo":"false", "showSpeakerName":"true", "showSpeakerTitle":"true", "staticTOC":"false"},"toc":{"enabled":"true", "showNotes":"false", "showOnRight":"true", "showOutline":"true", "showQuizOutline":"true", "showSearch":"true", "showThumbnails":"true"},"playbar":{"enabled":"true"}},
"contentReporting" : {"exitNormalIfCompleted":"false"
},
"toc" : [{"id" : "1256","title" : "Chapitre 1 : \nAspects Pharmacodynamiques"},
{"id" : "1257","title" : "La pharmacodynamie "},
{"id" : "1258","title" : ""},
{"id" : "1259","title" : ""},
{"id" : "1260","title" : " Antagoniste compétitif"},
{"id" : "1261","title" : "Réponses quantitatives"},
{"id" : "1262","title" : "Relation concentration\/effet"},
{"id" : "1266","title" : "Principaux paramètres \npharmacodynamiques"},
{"id" : "1274","title" : "Comparaison de puissance et \nd’efficacité de plusieurs ligands agonistes"},
{"id" : "1275","title" : "Le type de réponse étudiée"},
{"id" : "1278","title" : "Notion de marge thérapeutique"},
{"id" : "1280","title" : "Notion de marge thérapeutique"},
{"id" : "1281","title" : "Notion d’antagoniste"},
{"id" : "1283","title" : "Notion d’antagoniste compétitif"},
{"id" : "1284","title" : "Toxicologie des principes actifs"},
{"id" : "1287","title" : "Notion de concentration efficace 50"},
{"id" : "1288","title" : "Notion de concentration efficace 50"},
{"id" : "1290","title" : "Relation concentration-effet"},
{"id" : "1291","title" : "Relation concentration-effet"},
{"id" : "1295","title" : "Relation dose-réponse en toxicologie"},
{"id" : "1296","title" : "Relation dose-réponse en toxicologie"},
{"id" : "1297","title" : "Quantification de la puissance\nd’un antagoniste compétitif"},
{"id" : "1301","title" : "Quantification de la puissance\nd’un antagoniste compétitif"},
{"id" : "1313","title" : "Aspects\nPharmacologiques\n\nPrincipaux paramètres pharmacodynamiques"},
{"id" : "1316","title" : "Aspects\nPharmacologiques\n\nNotion de marge\nthérapeutique"},
{"id" : "1317","title" : "Aspects\nPharmacologiques\n\nNotion de toxicité\ndes médicaments"},
{"id" : "1319","title" : "Médicaments à marge thérapeutique étroite"},
{"id" : "1322","title" : "Activité intrinsèque d’un agoniste"},
{"id" : "1323","title" : "Les différents types de ligands"},
{"id" : "1324","title" : "Notion d’agoniste\nentier - agoniste partiel"},
{"id" : "1325","title" : "Les niveaux d’étude de l’affinité et de l’activité des principes actifs"},
{"id" : "1329","title" : "Objectifs\/Plan du cours"},
{"id" : "1330","title" : "Objectifs\/Plan du cours"},
{"id" : "1331","title" : "Comparaison de puissance et \nd’efficacité de plusieurs ligands agonistes"},
{"id" : "1332","title" : "Objectifs\/Plan du cours"},
{"id" : "1333","title" : "Aspects\nPharmacologiques\n\nNotion d’affinité d’un ligand pour son récepteur"},
{"id" : "1334","title" : "Affinité et modèle de la loi d’action de masse"},
{"id" : "1335","title" : "Etudes de liaisons"},
{"id" : "1336","title" : "Notion de constante d’affinité"},
{"id" : "1337","title" : "Objectifs\/Plan du cours"},
{"id" : "1338","title" : "Aspects\nPharmacologiques\n\nRelations concentrations (ou doses) -effets"},
{"id" : "1339","title" : "Objectifs\/Plan du cours"},
{"id" : "1340","title" : "Notion d’activité intrinsèque"},
{"id" : "1341","title" : "Antagonisme non compétitif"},
{"id" : "1342","title" : " Antagoniste non compétitif"}]}